SEC EDGARAUG 62 min read$NEOG

Nassif Mikheal purchased $4K of NEOG (indirect holdings)

Nassif Mikheal (CEO) purchased 370 indirectly-held shares of NEOGEN CORP (NEOG) at $11.81 on 2026-08-04.

Original reporting

SEC EDGAR · Nassif Mikheal

Published Aug 6, 2026, 12:16 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 6, 2026, 12:36 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$NEOG

Bullish

low confidence

Mentioned

$NEOG

Relevance

3/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$NEOGBullishLow

Why it matters

The CEO’s open-market purchase is a sentiment datapoint, but it does not include any new operational, financial, or regulatory information that would change valuation assumptions.

Market read

Traders may note the insider buy for sentiment, but the transaction size and lack of new fundamentals suggest limited trading impact.

What to watch

The article does not state the indirect holding structure details, and it provides no context on prior transactions or whether the purchase was part of broader compensation planning.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-08-06, covering a 2026-08-04 purchase.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for NEOGEN Corp.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$NEOGBullishLow confidence

Context

NEOGEN CEO Nassif Mikheal bought 370 shares on 2026-08-04 for $4,369.70, disclosed via Form 4 filed 2026-08-06.

Expected impact

Likely limited, short-lived sentiment effect; no clear directional signal beyond optics.

Evidence & confidence

Form 4 insider buys can be read as confidence, but the disclosed size is small and the filing provides no new company performance or guidance.

Market effects

Sector

No sector-wide implications; this is company-specific insider activity.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider buys can be routine liquidity or tax-related, and the indirect nature of the holdings reduces interpretability.

Key entities

issuer
NEOGEN CORP
Company whose CEO insider purchase is disclosed on Form 4.
insider
Nassif Mikheal
CEO and officer/director who reported an open-market purchase of 370 shares.

Read at source ← All news

SEP 17

$BLSMHighAI 8/10

Biotech Stocks At 52-Week Highs - BLSM +18% On Positive Trial Data, ADPT, ILMN, CBLL, NEOG

Biotech stocks BLSM, NEOG, ILMN, CBLL, and ADPT hit 52-week highs. BLSM rose 18% on positive trial data, NEOG grew 2% with Q4 revenue of $225M, ILMN reached $236 on 9.5% Q2 growth, CBLL hit $25.63 with Q2 revenue up 33%, and ADPT climbed 3% with full-year revenue forecast between $268M-$278M.

rttnews.com3 min

AUG 26

$ARGXMed

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Atlassian, Dick’s Sporting Goods, EPAM Systems, GoDaddy, Intuit, Jersey Mike’s Subs, JFrog, Lattice Semiconductor, and More

Wall Street analysts issued upgrades, downgrades, and initiations for several companies. Upgrades include argenx (ARGX) to Buy at UBS, DT Midstream (DTM) to Outperform at Wolfe Research, and SolarEdge (SEDG) to Buy at UBS. Downgrades include Dick's Sporting Goods (DKS) to Hold at Truist, EPAM Systems (EPAM) to Neutral at JPMorgan, and Intuit (INTU) to Neutral at Bank of America. Initiations include Atlassian (TEAM) with Outperform at RBC, JFrog (FROG) with Outperform at RBC, and Lattice Semicond

247wallst.com4 min

AUG 26

$NEOGMed

Why is Neogen stock climbing today?

Neogen Corporation (NEOG) stock rose 3.0% in pre-market trading after Piper Sandler upgraded it to Overweight and raised its price target to $14. The firm cited improved operating performance, accelerating growth in the Food Safety segment, and effective execution of a turnaround strategy. Neogen's recent earnings beat and raised guidance also contributed to the positive sentiment.

investing.com2 min

AUG 8

$NEOGMedAI 8/10

Neogen (NEOG) Q4 2026 Earnings Call Transcript

Neogen (NEOG) reported fiscal Q4 2026 revenue of $225.3 million, up 4.3% in core growth, led by Food Safety. Adjusted gross margin rose to 49.7% and adjusted EBITDA grew 12% to $45.4 million. FY2027 guidance: revenue $880-$885 million and adjusted EBITDA $180-$182 million. The company plans a 50% R&D increase and a $140 million genomics divestiture for debt reduction.

fool.com6 min

JUL 31

$CORTMed

Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCR

The following biotech stocks reached 52-week highs on July 30, 2026, driven by key catalysts such as positive quarterly reports or announced settlement agreements. Corcept Therapeutics Incorporated (CORT) Corcept is a biopharmaceutical company engaged in developing medications for metabolic, oncologic, and neurologic diseases. Shares surged over 30% on Thursday to a 52-week high of $122.21.

rttnews.com6 min